Mesotherapy
PLURYAL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 10995
·
GTIN 3760258821112
Pluryal Hair Density
In stock
Volume
1 x 2 mL
Laboratory
MD Skin solutions Laboratoires
Origin
Luxemburg
Indication
Androgenetic alopecia and hair loss support via polynucleotide biostimulation
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Pluryal Hair Density is a sterile, ready-to-use injectable polynucleotide (PN) biostimulator, CE-marked and reserved for medical practitioners only. Pluryal Hair Density polynucleotides are formulated for scalp and hair regeneration, indicated for hair loss conditions such as androgenetic alopecia and telogen effluvium, as well as post-hair transplantation support. The product contains 15 mg of polynucleotides per 2 mL syringe (7.5 mg/mL) and is intended strictly for professional use.
Key Benefits of Pluryal Hair Density
- Supports follicular stimulation through activation of dermal papilla cell activity
- Improves hair cycle dynamics, increasing the anagen/telogen ratio and reducing premature miniaturisation
- Provides anti-inflammatory action, reducing inflammatory mediators in the scalp
- Supports microcirculation, enhancing local perfusion, oxygenation and nutrient supply
- Promotes structural reinforcement around the follicle bulge, helping reduce hair shedding
- CE-marked Class III medical device for professional use
Indications and Professional Use
Main indications
- Androgenetic alopecia (in women and men)
- Telogen effluvium
- Adjuvant therapy: post-hair-transplant support, LED light and PRP
Professional use
Pluryal Hair Density is a class III medical device for professional use only, reserved for trained medical practitioners. It is administered by intradermal injection into the deep dermis of the scalp using a microbolus, multi-puncture or linear threading technique. Indicated for androgenetic alopecia, telogen effluvium and as adjuvant therapy after hair transplant, LED light or PRP. For androgenetic alopecia the protocol is 10 sessions over 4 months, followed by monthly maintenance.
Treatment areas
- Scalp: frontotemporal region, mid-scalp and vertex
- Eyebrows
- Beard
Patient profile
Suitable for adult men and women across androgenetic alopecia stages I–IV, with telogen effluvium, or requiring post-transplant support, following clinical assessment. A clinical study of 20 patients (10 men, 10 women; mean age 37.7 ± 8.1) published in the Archives of Dermatological Research reported a significant reduction in hair shedding, an increased anagen/telogen ratio, a 24.2% increase in terminal hairs at week 24 and improved hair thickness, with only mild, transient adverse effects and no serious adverse events.
How Pluryal Hair Density Works
Pluryal Hair Density works through polynucleotides at 7.5 mg/mL, injected intradermally into the scalp to activate metabolic pathways and A2A purinergic receptors that promote dermal papilla cell activity. This supports improved hair cycle dynamics, reduces inflammatory mediators, enhances local microcirculation, and promotes structural reinforcement around the follicle bulge - together supporting scalp and hair regeneration in androgenetic alopecia, telogen effluvium and post-transplantation recovery.
Why Order From Allpara
Allpara offers genuine, verified PLURYAL products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Which areas does Pluryal Hair Density treat?
The scalp — the frontotemporal region, mid-scalp and vertex — for androgenetic alopecia, telogen effluvium and post-hair-transplant support.
Is there clinical evidence for Pluryal Hair Density?
Yes. A clinical study of 20 patients with androgenetic alopecia, published in the Archives of Dermatological Research, reported a significant reduction in hair shedding, an increased anagen/telogen ratio and a 24.2% increase in terminal hairs at week 24, with no serious adverse events.
How many sessions of Pluryal Hair Density are needed?
For androgenetic alopecia the recommended course is 10 intradermal sessions over 4 months, followed by monthly maintenance. Telogen effluvium is treated with 3 monthly sessions, repeated after 6 months if needed.
More from MD Skin solutions Laboratoires
Biorevitalisation
Dermal Fillers
Clinic alternatives
Aesthetic Skincare
/ Recently viewed
Pick up where you left off
Pluryal Hair Density
In stock
CE Marked
Pluryal Hair Density is a sterile, ready-to-use injectable polynucleotide (PN) biostimulator, CE-marked and reserved for medical practitioners only. Pluryal Hair Density polynucleotides are formulated for scalp and hair regeneration, indicated for hair loss conditions such as androgenetic alopecia and telogen effluvium, as well as post-hair transplantation support. The product contains 15 mg of polynucleotides per 2 mL syringe (7.5 mg/mL) and is intended strictly for professional use.
Key Benefits of Pluryal Hair Density
- Supports follicular stimulation through activation of dermal papilla cell activity
- Improves hair cycle dynamics, increasing the anagen/telogen ratio and reducing premature miniaturisation
- Provides anti-inflammatory action, reducing inflammatory mediators in the scalp
- Supports microcirculation, enhancing local perfusion, oxygenation and nutrient supply
- Promotes structural reinforcement around the follicle bulge, helping reduce hair shedding
- CE-marked Class III medical device for professional use
Indications and Professional Use
Main indications
- Androgenetic alopecia (in women and men)
- Telogen effluvium
- Adjuvant therapy: post-hair-transplant support, LED light and PRP
Professional use
Pluryal Hair Density is a class III medical device for professional use only, reserved for trained medical practitioners. It is administered by intradermal injection into the deep dermis of the scalp using a microbolus, multi-puncture or linear threading technique. Indicated for androgenetic alopecia, telogen effluvium and as adjuvant therapy after hair transplant, LED light or PRP. For androgenetic alopecia the protocol is 10 sessions over 4 months, followed by monthly maintenance.
Treatment areas
- Scalp: frontotemporal region, mid-scalp and vertex
- Eyebrows
- Beard
Patient profile
Suitable for adult men and women across androgenetic alopecia stages I–IV, with telogen effluvium, or requiring post-transplant support, following clinical assessment. A clinical study of 20 patients (10 men, 10 women; mean age 37.7 ± 8.1) published in the Archives of Dermatological Research reported a significant reduction in hair shedding, an increased anagen/telogen ratio, a 24.2% increase in terminal hairs at week 24 and improved hair thickness, with only mild, transient adverse effects and no serious adverse events.
How Pluryal Hair Density Works
Pluryal Hair Density works through polynucleotides at 7.5 mg/mL, injected intradermally into the scalp to activate metabolic pathways and A2A purinergic receptors that promote dermal papilla cell activity. This supports improved hair cycle dynamics, reduces inflammatory mediators, enhances local microcirculation, and promotes structural reinforcement around the follicle bulge - together supporting scalp and hair regeneration in androgenetic alopecia, telogen effluvium and post-transplantation recovery.
Why Order From Allpara
Allpara offers genuine, verified PLURYAL products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Which areas does Pluryal Hair Density treat?
The scalp — the frontotemporal region, mid-scalp and vertex — for androgenetic alopecia, telogen effluvium and post-hair-transplant support.
Is there clinical evidence for Pluryal Hair Density?
Yes. A clinical study of 20 patients with androgenetic alopecia, published in the Archives of Dermatological Research, reported a significant reduction in hair shedding, an increased anagen/telogen ratio and a 24.2% increase in terminal hairs at week 24, with no serious adverse events.
How many sessions of Pluryal Hair Density are needed?
For androgenetic alopecia the recommended course is 10 intradermal sessions over 4 months, followed by monthly maintenance. Telogen effluvium is treated with 3 monthly sessions, repeated after 6 months if needed.
More from MD Skin solutions Laboratoires
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.